FDA Discovers Second Impurity in Chinese Manufacturer’s Valsartan

Drug Industry Daily
A A
Another impurity has been detected in Zhejiang Huahai Pharmaceuticals’ ill-fated active ingredient valsartan, the FDA announced Thursday.

To View This Article:

Login

Subscribe To Drug Industry Daily